Celera Group

Epigenomics CEO German-US molecular diagnostics company Epigenomics AG has appointed Gregory Hamilton as its new CEO. Hamilton succeeds Thomas Taapken , who served as both CEO and chief financi

Genentech Inc. is looking for business development deals and licensing opportunities that will continue the biotech giant's expansion of its biomarker-based approach to drug development beyond the o

AbbVie Inc. was prepared to pay big to win Pharmacyclics Inc. in a competitive acquisition process, outbidding two rivals in the final round of negotiations, according to CEO Richard Gonzalez. T

Despite a slight slowdown, there’s considerable cash already sloshing around the biotech IPO space. There’s (still!) plenty more stacked up in investor suitcases from California to the New York Island